Walnuts (Juglans regia) Chemical Composition and Research in Human Health

Critical Reviews in Food Science and Nutrition

Volumn 56, Issue 8, 2016, Pages 1231-1241

  Hayes, David ^a   Angove, Michael J ^a   Tucci, Joe ^a   Dennis, Christina ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

anti carcinogenic; carcinolysis; cardiovascular disease; cytotoxic; diabetes; fatty acids; neurological; phytochemicals; Walnuts

Indexed keywords

CARDIOLOGY; FATTY ACIDS; FORESTRY; FREE RADICALS; HEALTH; HEALTH RISKS; MEDICAL PROBLEMS; NEUROLOGY; NUCLEIC ACIDS; POLYUNSATURATED FATTY ACIDS;

ANTI-CARCINOGENIC; CARCINOLYSIS; CARDIO-VASCULAR DISEASE; CYTOTOXIC; NEUROLOGICAL; PHYTOCHEMICALS; WALNUTS;

DISEASES;

ANTIOXIDANT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYPHENOL; UNSATURATED FATTY ACID;

ANIMAL; CARDIOVASCULAR DISEASES; CHEMISTRY; DIET; DIETARY SUPPLEMENT; HEALTH PROMOTION; HUMAN; NEOPLASMS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUT; WALNUT;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIET; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; HEALTH PROMOTION; HUMANS; JUGLANS; NEOPLASMS; NUTS; POLYPHENOLS;

EID: 84975132523     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2012.760516     Document Type: Article

References (123)

1. G.Ailhaud,, P.Guesnet, and S.C.Cunnane, (2008). An emerging risk factor for obesity: Does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development? Br. J. Nutr. 100:461–470.
2. C.Alasalvar, and F.Shahidi, (2008). Tree Nuts: Composition, Phytochemicals, and Health Effects. CRC Press, Boca Raton, FL.
3. American Diabetes Association (2004): Nutrition principles and recommendations in diabetes (Position Statement). Diabetes Care27(Suppl. 1): S36–S46.
4. R.J.Anderson,, K.E.Freedland,, R.E.Clouse, and P.J.Lustman, (2001). The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care. 24:1069–1078.
5. K.N.Aronis,, M.T.Vamvini, and J.P.Chamberland, (2011). Short-term walnut consumption increases circulating total adiponectin and apolipoprotein a concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: Data from a double blinded, randomized, placebo-controlled study. Metabolism. 61:577–582.
6. B.J.Arsenault,, J.P.Despres,, E.S.Stroes,, N.J.Wareham, and J.J.Kastelein, (2010). Lipid assessment, metabolic syndrome and coronary heart disease risk. Eur. J. Clin. Invest. 40:1081–1093.
7. M.Asadi Shekaari,, T.P.Kalantaripour,, N.F.Arab,, E.Namazian, and A.Eslami, (2012). The anticonvulsant and neuroprotective effects of walnuts on the neurons of rat brain cortex. Avicenna J. Med. Biotech. (AJMB)4:155–158.
8. A.Astrup,, J.Dyerberg, and P.Elwood, (2011). The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: Where does the evidence stand in 2010? Am. J. Clin. Nutr. 93:684–688.
9. U.C.Bhargava, and B.A.Westfall, (1968). Antitumor activity of Juglans nigra (Black Walnut) extractives. J. Pharm. Sci. 57:1674–1677.
10. A.H.Barnett, (2009). New treatments in type 2 diabetes: A focus on the incretin-based therapies. Clin. Endocrinol. 70:343–353.
11. H.Bartsch,, J.Nair, and R.W.Owen, (1999). Dietary PUFAs and cancer of the breast and colorectum: Compelling evidence for their role as risk modifiers. Carcinogenesis. 20:2209–2218.
12. V.Bashkatova,, V.Narkevich,, G.Vitskova,, and A.Vanin, (2003). The influence of anticonvulsant and antioxidant drugs on nitric oxide level and lipid peroxidation in the rat brain during penthylenetetrazole-induced epileptiform model seizures. Prog Neuro-Psychopharmacol. Biol. Psychiatry. 27:487–492.
13. E.C.Bate-Smith, (1972). Detection and determination of ellagitannins. Phytochemistry. 11:1153–1156.
14. J.A.Baur, and D.A.Sinclair, (2006). Therapeutic potential of resveratrol: The in vivo evidence. Nature Rev. Drug Discov. 5:493–506.
15. M.E.Begin,, U.N.Das,, G.Ells, and D.F.Horrobin, (1985). Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukot. Med. 19:177–186.
16. I.M.Berquin,, I.J.Edwards, and Y.Q.Chen, (2008). Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Letters. 269(2):363–377.
17. E.Bingham, and S.Morris, (1988). Complex mixtures and multiple agent interactions: The issues and their significance. Fundam. Appl. Toxol. 10:549–552.
18. B.W.Bolling,, C.Y.O.Chen,, D.L.McKay, and J.B.Blumberg, (2011). The phytochemical composition of tree nuts. Nutr. Res. Rev. 24:244–275.
19. M.Boukharta,, G.Jalbert, and A.Castonguay, (1992). Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Nutr. Cancer. 18:181–189.
20. A.M.Brennan,, L.L.Sweeney,, X.Liu, and Mantzoros, C.S. (2010). Walnut consumption increases satiation but has no effect on insulin resistance or the metabolic profile over a 4-day period. Obesity 18:1176–1182.
21. B.C.Campbell,, R.J.Molyneux, and T.F.Schatzki, (2003). Current research on reducing pre- and post-harvest aflatoxin contamination of US almond, pistachio, and walnut. J. Toxicol. Toxin. Rev. 22:225–266.
22. J.S.Carrion,, N.Fuentes,, P.Gonzalez-Samperiz,, L.Sanchez Quirante,, J.C.Finlayson,, S.Fernandez, and A.Andrade, (2007). Holocene environmental change in a montane region of southern Europe with a long history of human settlement. Quat. Sci. Rev. 26(11–12):1455–1475.
23. M.Carvalho,, P.J.Ferreira,, V.S.Mendes,, R.Silva,, J.A.Pereira, and C.Jerónimo, (2010). Human cancer cell antiproliferative and antioxidant activities of Juglans regia L. Food Chem. Toxicol. 48:441–447.
24. P.Casas-Agustench,, P.Lopez-Uriarte,, E.Ros,, M.Bullo, and J.Salas-Salvado, (2011a). Nuts, hypertension and endothelial function. Nutr. Met. Cardiovasc. Dis. 21(Suppl. 1):S21–S33.
25. P.Casas-Agustench,, A.Salas-Huetos, and J.Salas-Salvado, (2011b). Mediterranean nuts: Origins, ancient medicinal benefits and symbolism. Public Health Nutr. 14(Suppl. 1):2296–2301.
26. B.Cerda,, F.A.Tomas-Barneran, and J.C.Espin, (2005). Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: Identification of biomarkers and individual variability. J. Agric. Food Chem. 53:227–235.
27. C.Y.Chen, and J.B.Blumberg, (2008). Phytochemical composition of nuts. Asia Pacific J. Clinic. Nut. 17(Suppl. 1):329–332.
28. G.A.Colditz,, E.Burdick, and F.Mosteller, (1995). Heterogeneity in meta-analysis of data from epidemiologic studies: A commentary. Am. J. Epidemiol. 142:371–382.
29. Colditz, G.A., Manson, J.E., and Hankinson, S.E. (1997). The Nurses' Health Study: 20-Year Contribution to the Understanding of Health Among Women. J Women's Health. 6(1): 49–62.
30. S.Czernichow,, D.Thomas, and E.Bruckert, (2010). n-6 Fatty acids and cardiovascular health: A review of the evidence for dietary intake recommendations. Br. J. Nutr. 104:1–9.
31. E.M.Daniel,, A.S.Krupnick,, Y.H.Heur,, J.A.Blinzler,, R.W.Nims, and G.D.Stoner, (1989). Extraction, stability, and quantitation of ellagic acid in various fruits and nuts. J. Food Comp. Anal. 2:338–349.
32. P.Davis,, G.Valacchi,, E.Pagnin,, Q.Shao,, H.B.Gross,, L.Calo, and W.Yokoyamaz, (2006). Walnuts reduce aortic ET-1 mRNA levels in hamsters fed a high-fat, atherogenic diet. J. Nutr. 136:428–432.
33. P.A.Davis,, V.T.Vasua,, K.Gohila,, H.Kima,, I.H.Khana,, E.Carroll, and W.Yokoyama, (2012). A high-fat diet containing whole walnuts (Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model. Brit. J. Nutr. 108:1–9.
34. J.N.Din,, S.M.Aftab,, A.W.Jubb,, F.H.Carnegy, and K.Lyall, (2011). Effect of moderate walnut consumption on lipid profile, arterial stiffness and platelet activation in humans. Eur. J. Clin. Nutr. 65:234–239.
35. R.Doll, and R.Peto, (1981). The causes of cancer in the United States today. J. Nat. Cancer Inst. 66:1192–1308.
36. I.Elmadfa, and M.Kornsteiner, (2009). Dietary fat intake – A global perspective. Ann. Nutr. Metab. 54(Suppl. 1):8–14.
37. J.C.Espin,, M.T.Garcia-Conesa, and F.A.Tomas-Barberan, (2007). Nutraceuticals: Facts and fiction. Phytochemistry. 68:2896–3008.
38. J.C.Espin,, R.Gonzalez-Barrio, and B.Cerda, (2007). Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. J. Agric. Food Chem. 55:10476–10485.
39. E.B.Feldman, (2002). The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. J. Nutr. 132:1062S–1101S.
40. E.S.Ford,, D.F.Williamson, and S.Liu, (1997). Weight change and diabetes incidence: Findings from a national cohort of US adults. Am. J. Epidemiol. 146:214–222.
41. T.Fukuda,, H.Ito and T.Yoshida, (2003). Antioxidative polyphenols from walnuts (Juglans regia L.). Phytochemistry. 63:795–801.
42. X.Gao,, A.Cassidy,, M.A.Schwarzschild,, E.B.Rimm, and A.Ascherio, (2012). Habitual intake of dietary flavonoids and risk of Parkinson's disease. Neurology. 78:1138–1145.
43. M.Gerber, (2009). Background review paper on total fat, fatty acid intake and cancers. Ann. Nutr. Metab. 55:140–161.
44. L.S.Gillen, and L.C.Tapsell, (2005). Structured dietary advice incorporating walnuts achieves optimal fat and energy balance in patients with type 2 diabetes mellitus. J. Am. Diet. Assoc. 105:1087–1096.
45. N.Gunduc, and S.N.El, (2003). Assessing antioxidant activities of phenolic compounds of common Turkish food and drinks on in vitro low-density lipoprotein oxidation. J. Food Sci. 68:2591–2595.
46. T.Hamazaki, and H.Okuyama, (2003). The Japan society for lipid nutrition recommends to reduce the intake of linolenic acid. A review and critique of the scientific evidence. In Omega-6/Omega-3 Essential Fatty Acid Ratio: The scientific evidence, volume eds. A P Simopoulos and L G Cleland. World Rev. Nutr. Diet. 92:109–132.
47. Y.S.Han,, S.Bastianetto,, Y.Dumont, and R.Quirion, (2006). Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J. Pharmacol. Exp. Ther. 318:238–245.
48. W.E.Hardman, and G.Ion, (2008). Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut. Nutr. Cancer 60:666–674.
49. W.E.Hardman,, G.Ion,, J.A.Akinsete, and T.R.Witte, (2011). Dietary walnut suppressed mammary gland tumorigenesis in the C(3)1 TAg mouse. Nutr. Cancer. 63:960–970.
50. J.M.Harnly,, R.F.Doherty,, G.R.Beecher,, J.M.Holden,, D.B.Haytowitz,, S.Bhagwat, and S.Gebhardt, (2006). Flavonoid content of US fruits, vegetables, and nuts. J. Agric. Food. Chem. 54:9966–9977.
51. F.B.Hu,, J.E.Manson,, M.J.Stampfer,, G.Colditz,, S.Liu,, C.G.Solomon, and W.C.Willett, (2001). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med. 345:790–797.
52. F.B.Hu,, M.J.Stampfer, and E.Rimm, (1999). Dietary fat and coronary heart disease. Am. J. Epidemiol. 149:531–540.
53. P.Huang,, V.Chandra, and F.Rastinejad, (2010). Structural overview of the nuclear receptor superfamily: Insights into physiology and therapeutics. Ann. Rev. Physiol. 72:247–272.
54. International Nut and Dried Fruit Foundation. (2010). Nuts and Dried Fruits Global Statistical Review 2004–2009. INC, Reus, Spain.
55. H.Ito, T.Okuda,, T.Fukuda,, T.Hatano, and T.Yoshida, (2007) Two novel dicarboxylic acid derivatives and a new dimeric hydrolysable tannin from walnuts. J. Agric. Food Chem. 55:672– 679.
56. R.Jiang,, J.E.Manson,, M.J.Stampfer,, S.Liu,, W.C.Willett, and F.B.Hu, (2002). Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA 288:2554–2560.
57. W.Jiang, H.Oken, M.Fiuzat, L.K.Shaw,, C.Martsberger,, M.Kuchibhatla,, R.Kaddurah-Daouk,, D.C.Steffens,, R.Baillie,, M.Cuffe,, R.Krishnan, and C.O’Connor, (2012). Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder. J Cardiovasc Transl Res. 5:92–99.
58. J.A.Joseph,, B.Shukitt-Hale, and L.M.Willis, (2009). Grape juice, berries, and walnuts affect brain aging and behavior. J. Nutr. 139:1813S–1817S.
59. Y.Kagawa, (2001). In: Standard Tables of Food Composition in Japan. Kagawa Nutrition University Press, Tokyo, Japan.
60. C.W.C.Kendall,, A.Esfahani,, A.R.Josse,, L.S.A.Augustin,, E.Vidgen, and D.J.A.Jenkins, (2011). The glycaemic effect of nut-enriched meals in healthy and diabetic subjects. Nutr. Metab. Cardiovasc. Dis. 21(Suppl. 1):S34–S39.
61. A.Keys,, J.T.Anderson, and F.Grande, (1957). Prediction of serum-cholesterol responses of man to changes in the diet. Lancet. 273:959–966.
62. M.J.Knol,, J.W.Twisk,, A.T.Beekman,, R.J.Heine,, F.J.Snoek, and F.Pouwer, (2006). Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 49:837–845.
63. H.Kolb, and T.Mandrup-Poulsen, (2005). An immune origin of type 2 diabetes? Diabetologia. 48:1038–1050.
64. H.Kolb, and T.Mandrup-Poulsen, (2010). The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia. 53:10–20.
65. P.T.Kuo,, A.F.Whereat,, D.R.Bassett, and Ezra. (1961). Patterns of hyperlipaemic patients before and after the ingestion of different study of the mechanism of hyperlipaemia: Serum chylomicron fatty acid. Circulation. 24:213–222.
66. D.O.Labuckas,, D.M.Maestri,, M.Perello,, M.L.Martinez, and A.L.Lamarque, (2008). Phenolics from walnut (Juglans regia L.) kernels: Antioxidant activity and interactions with proteins. Food Chem. 107:607–612.
67. S.C.Larsson,, M.Kumlin,, M.Ingelman-Sundberg, and A.Wolk, (2004). Dietary long-chain n-3 fatty acids for the prevention of cancer: A review of potential mechanisms. Am. J. Clin. Nutr. 79:935–945.
68. L.Li,, R.Tsao,, R.Yang,, J.Kramer, and M.Hernandez, (2007). Fatty acid profiles, tocopherol contents, and antioxidant activities of heartnut (Juglans ailanthifolia var. cordiformis) and Persian walnut (Juglans regia L.). J. Agric. Food Chem. 55:1164–1169.
69. L.S.Maguire,, S.M.O'sullivan,, K.Galvin,, T.P.O'Connor, and N.M.O'Brien, (2004). Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. J. Food Sci. Nutr. 55:171–178.
70. V.Manninen,, M.Olli Elo,, F.Heikki,, H.Kauko,, O.Heinonen,, P.Heinsalmi,, P.Helo,, J.K.Huttunen,, P.Kaitaniemi,, P.Koskinen,, H.Mäenpää,, M.Mälkönen,, M.Mänttäri,, S.Norola,, A.Pasternack,, J.Pikkarainen,, M.Romo,, T.Sjöblom, and E.A.Nikkilä, (1988). Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. J. Am. Med. Assoc. 260:641–651.
71. C.S.Mantzoros,, C.J.Williams,, J.E.Manson,, J.B.Meigs, and F.B.Hu, (2006). Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am. J. Clin. Nutr. 84:328–335.
72. M.A.Martinez-Gonzalez,, D.Corella,, J.Salas-Salvado,, E.Ros,, M.I.Covas,, M.Fiol,, J.Warnberg,, F.Aros,, V.Ruiz-Gutierrez,, R.M.Lamuela-Raventos,, J.Lapetra,, M.A.Munoz,, J.A.Martinez,, G.Saez,, L.Serra-Majem,, X.Pinto,, M.T.Mitjavila,, J.A.Tur,, M.D.Portillo,, R.Estruch, and the PREDIMED Study Investigators. (2010). Cohort profile: Design and methods of PREDIMED study. Int. J. Epidemiol. 41(2):377–385.
73. D.R.Matthews,, J.P.Hosker,, A.S.Rudenski,, B.A.Naylor,, D.F.Treacher, and R.C.Turner, (1985). Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412–419.
74. M.Mazza,, M.Pomponi,, L.Janiri,, P.Bria, and S.Mazza, (2007). Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. Prog. Neuro.Psychopharmacol. Biol. Psych. 31:12–26.
75. A.Medina-Remon,, A.Barrionuevo-Gonzalez,, R.Zamora-Ros,, C.Andres-Lacueva,, R.Estruch,, M.A.Martina-Gonzalez,, J.Diez-Espino, and R.M.Lamuela-Raventos, (2009). Rapid Folin-Ciocalteu method using microtiter 96-well plate cartridges for solid phase extraction to assess urinary total phenolic compounds as a biomarker of total polyphenol intake. Anal. Chim. Acta 634: 54–60.
76. R.P.Mensink,, P.L.Zock,, A.D.Kester, and M.B.Katan, (2003). Effect of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77:1146–1155.
77. A.Mente,, L.de Koning,, H.S.Shannon, and S.S.Anand, (2009). A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch. Intern. Med. 169:659–669.
78. R.Micha, and D.Mozaffarian, (2010). Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: A fresh look at the evidence. Lipids. 45:893–905.
79. O.Molendi-Coste,, V.Legry, and I.A.Leclercq, (2011). Why and how meet n-3 PUFA Dietary Recommendations? Gastroenterol. Res. Pract. 2011:364.
80. Nagel, J.M., Brinkoetter, M., Magkos, F., Liu, X., Chamberland, J.P., Shah, S., Zhou, J., Blackburn, G., and Mantzoros, C.S. (2012). Dietary walnuts inhibit colorectal cancer growth in mice by suppressing angiogenesis. Nutrition. 28:67–75.
81. J.M.Nagel,, M.Brinkoetter,, F.Magkos,, X.Liu,, J.P.Chamberland,, S.Shah,, J.Zhou,, G.Blackburn, and C.S.Mantzoros, (2012). Dietary walnuts inhibit colorectal cancer growth in mice by suppressing angiogenesis. Nutrition. 28:67–75.
82. News Review. 2010. Lipid technology 5/2010. Lipid Technol. 22:99–102.
83. K.Ohashia,, N.Ouchia, and Y.Matsuzawab, (2012). Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie. 94:21137–2142.
84. E.A.Oshaghi1,, A.N.Sorkhani, and A.Rezaei1, (2012). Effects of walnut on lipid profile as well as the expression of sterol-regulatory element binding protein-1c(SREBP-1c) and peroxisome proliferator activated receptors α (PPARα) in diabetic rat. Food Nutri. Sci. 3:255–259.
85. N.Ouchi,, H.Kobayashi,, S.Kihara,, M.Kumada,, K.Sato,, T.Inoue,, T.Funahashi, and K.Walsh, (2004). Adiponectin stimulates angiogenesis by promoting cross-talk between AMP activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 279:1304–1309.
86. Z.Papoutsi,, E.Kassi,, I.Chinou,, M.Halabalaki,, L.A.Skaltsounis, and P.Moutsatsou, (2008). Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br. J. Nutr. 99:715–722.
87. E.J.Park, and J.M.Pezzuto, (2012). Flavonoids in cancer prevention. Anticancer Agents Med. Chem. 12(8):836–851.
88. P.Pribis,, R.N.Bailey,, A.A.Russell,, M.A.Kilsby,, M.Hernandez,, W.J.Craig,, T.Grajales,, D.J.Shavlik, and J.Sabate, (2012). Effects of walnut consumption on cognitive performance in young adults. Br. J. Nutr. 107:1393–1401.
89. A.Rey, (1964). L'examen Clinique en Psychologie. Presses Universitaires de France, Paris, France.
90. E.Ros, (2009). Nuts and novel biomarkers of cardiovascular disease. Am. J. Clin. Nutr. 89:1649S–1656S.
91. E.Ros,, I.Nunez,, A.Perez-Heras,, M.Serra,, R.Gilabert, and E.Casals, (2004). A walnut diet improves endothelial function in hypercholesterolemic subjects: A randomized crossover trial. Circulation. 109:1609–1614.
92. G.L.Russo, (2009). Dietary n-6 and n-3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention. Biochem. Pharmacol. 77:937–946.
93. J.Sabate, (1993). Does nut consumption protest against ischemic heart disease? Eur. J. Clin. Nutr. 47:71–5S.
94. J.Sabate,, Z.Cordero-Macintyre,, G.Siapco,, S.Torabian, and E.Haddad, (2005). Does regular walnut consumption lead to weight gain? Br. J. Nutr. 94:859–864.
95. J.Salas-Salvado,, M.Bullo,, N.Babio,, M.Martinez-Gonzalez,, N.Ibarrola-Jurado,, J.Basora,, R.Estruch,, M.Covas,, D.Corella,, F.Aros,, V.Ruiz-Gutierrez, and E.Ros, (2011). Reduction in the incidence of type 2 diabetes with the mediterranean diet. Diabetes Care. 34:14–19.
96. M.Shakibaei,, K.B.Harikumar, and B.B.Aggarwal, (2009). Resveratrol addiction: To die or not to die. Mol. Nutr. Food Res. 53:115–128.
97. J.E.Shaw,, R.A.Sicree, and P.Z.Zimmet, (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87:4–14.
98. H.Shu,, B.Wong,, G.Zhou,, Y.Li,, J.Berger,, J.W.Woods,, S.D.Wright, and T.Q.Cai, (2000). Activation of PPARα or γ reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells. Biochem. Biophys. Res. Commun. 267:345–349.
99. J.A.Simon,, Y.H.Chen, and S.Bent, (2009). The relation of a-linolenic acid to the risk of prostate cancer: A systematic review and meta-analysis. Am. J. Clin. Nutr. 89(Suppl):1558S–1596S.
100. A.P.Simopoulos, (2008). The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. 233:674–688.
101. P.Singh,, A.Kumar,, N.K.Dubey, and R.Gupta, (2009). Essential oil of Aegle marmelos as a safe plant-based antimicrobial against postharvest microbial infestations and aflatoxin contamination of food commodities. J. Food Sci. 74:302–307.
102. V.L.Singleton,, R.Orthofer, and R.M.Lamuela-Raventos, (1999). Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol. 299:152–178.
103. P.W.Siri-Tarino,, Q.Sun,, F.B.Hu, and R.M.Krauss, (2010). Saturated fat, carbohydrate, and cardiovascular disease. Am. J. Clin. Nutr. 91:502–509.
104. J.M.Smoliga,, J.A.Baur,, and H.A.Hausenblas, (2011). Resveratrol and health – A comprehensive review of human clinical trials. Mol. Nutr. Food Res. 55:1129–1141.
105. K.J.Spaccarotella,, P.M.Kris-Etherton,, W.L.Stone,, D.M.Bagshaw,, V.K.Fishell,, S.G.West,, F.R.Lawrence, and T.J.Hartman, (2008). The effect of walnut intake on factors related to prostate and vascular health in older men. Nutr. J. 2:7–13.
106. J.Spranger,, M.Mohlig,, U.Wegewitz,, M.Ristow,, A.F.Pfeiffer,, T.Schill,, Schlosser, H.W. Brabant, G. and Schofl, C. (2004). Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin. Endocrinol. 61:738–746.
107. C.M.Steppan,, S.T.Bailey,, S.Bhat, S., Brown, E.J., Banerjee, R.R., Wright,C.M., Hiralben R. Patel, Ahima R.S. and Lazar, M.A. (2001). The hormone resistin links obesity to diabetes. Nature. 409:307–312.
108. G.D.Stoner, and H.Mukhtar, (1995). Polyphenols as cancer chemopreventive agents. J. Cell Biochem. Suppl. 22:169–180.
109. K.W.Sze-Tao,, J.E.Schrimpf,, S.S.Teuber,, K.H.Roux, and S.K.Sathe, (2001). Effects of processing and storage on walnut (Juglans regia L.) tannins. J. Sci. Food Agric. 81:1215–1222.
110. L.C.Tapsell,, L.J.Gillen,, C.S.Patch,, M.Batterham,, A.Owen,, M.Baré, and M.Kennedy, (2004). Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care. 27:2777–2783.
111. S.Torabian,, E.Haddad,, Z.Cordero-Macintyre,, J.Tanzman,, M.L.Fernandez, and J.Sabate, (2010). Long-term walnut supplementation without dietary advice induces favorable serum lipid changes in free-living individuals. Eur. J. Clin. Nutr. 64:274.
112. S.Umesalma, and G.Sudhandiran, (2011). Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway. Eur. J. Pharmacol. 660:249–258.
113. U.S. Department of Agriculture Nutrient Data Base at http://ndb.nal.usda.gov/ndb/search Accessed 2012.
114. C.Valls-Pedret,, R.S.Lamuela-Raventos,, A.Medina-Remon,, M.Quintana,, C.Dolores,, X.Pinto,, M.A.Martinez-Gonzalez,, R.Estruch, and E.Ros, (2012). Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk. J. Alzheimer's Dis. 29:773–782.
115. J.A.Vinson, and Y.Cai, (2011). Nuts, especially walnuts, have both antioxidant quantity and efficacy and exhibit significant potential health benefits. Food Funct. 3:134–140.
116. J.A.Vinson, and B.A.Honz, (1995). Phenol antioxidant index: Comparative antioxidant effectiveness of red and white wines. J. Agric Food Chem. 43:401–403.
117. F.Visioli,, C.A.Lastra, and C.Andres-Lacueva, (2011). Polyphenols and human health: A prospectus. Crit. Rev. Food Sci. Nutr. 51:524–546.
118. W.C.Willett, (2012). Dietary fats and coronary heart disease. J. Int. Med. 272:13–24.
119. C.D.Williams,, B.M.Whitley,, C.Hoyo,, D.J.Grant,, J.D.Iraggi,, K.A.Newman,, L.Gerber,, L.A.Taylor,, M.G.McKeever, and S.J.Freedland, (2011). A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Nutr. Res. 31:1–8.
120. L.M.Willis,, B.Shukitt-Hale,, V.Cheng, and J.A.Joseph, (2009). Dose-dependent effects of walnuts on motor and cognitive function in aged rats. British J. Nutr. 101, 1140–1144.
121. A.W.Wood,, M.T.Huang,, R.L.Chang,, H.L.Newmark,, R.E.Lehr,, H.Yagi,, J.M.Sayer,, D.M.Jerina, and A.H.Conney, (1982). Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols exceptional activity of ellagic acid. Proc. Nat. Acad Sci. 79:5513–5517.
122. T.Yamauchi,, J.Kamon,, H.Waki,, Y.Terauchi,, N.Kubota,, K.Hara,, Y.Mori,, T.Ide,, K.Murakami,, N.Tsuboyama-Kasaoka,, O.Ezaki,, Y.Akanuma,, O.Gavrilova,, C.Vinson,, M.L.Reitman,, H.Kagechika,, K.Shudo,, M.Yoda,, Y.Nakano,, K.Tobe,, R.Nagai,, S.Kimura,, M.Tomita,, P.Froguel, and T.Kadowaki, (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:941–946.
123. F.Ziemke, and C.S.Mantzoros, (2010). Adiponectin in insulin resistance: Lessons from translational research. Am. J. Clin. Nutr. 91(Suppl.):258S–261S.